Alla studier
RekryteringOBSERVATIONELL

Lysosomal Acid Lipase (LAL) Deficiency Registry

This study is a worldwide registry focusing on a rare genetic condition called Lysosomal Acid Lipase (LAL) Deficiency. This condition means the body struggles to break down certain fats, which can lead to various health problems, including liver issues. The registry aims to collect health information over time from people with LAL Deficiency to better understand the disease and how best to care for patients. It will also look at how effective treatments, like sebelipase alfa, are. Participation is entirely voluntary for both patients and doctors, and it's built to create a knowledge base that will help improve future treatment and support.

Överblick

Status
Rekrytering
Sponsor
Alexion Pharmaceuticals, Inc.
Inskrivningsmål
300
Starta
30 May 2013
Beräknad slutförande
30 Aug 2029

Vad handlar denna studie om?

Imagine your body as a busy factory with tiny clean-up crews called enzymes. In a rare condition called Lysosomal Acid Lipase (LAL) Deficiency, one of these clean-up enzymes isn't working properly. This enzyme is supposed to break down certain fats in your body. When it doesn't, these fats can build up in different organs, like the liver and spleen, causing health problems.

This condition can affect people differently. In babies, it's very serious and used to be called Wolman Disease. In older children and adults, it's often referred to as Cholesteryl Ester Storage Disease (CESD). In all cases, this build-up of fats can lead to issues such as liver damage, problems with blood cells, and difficulties absorbing nutrients from food. It can also increase the risk of heart and blood vessel problems.

Because LAL Deficiency is quite rare, doctors and researchers don't have all the answers yet. That's why this study, called the LAL Deficiency Registry, is so important. It's like a central database where information about many patients from around the world can be collected over time. By observing how the disease progresses, how it affects different people, and how various treatments work, the registry hopes to create a better understanding of LAL Deficiency. This knowledge will then be used to improve the care and support given to everyone living with this condition.

Viktiga punkter

  • It's a study aiming to understand a rare fat storage disorder called LAL Deficiency.
  • It collects ongoing health information from people with the condition worldwide.
  • It does not involve new treatments or medical procedures.
  • Its goal is to improve future care and treatment for LAL Deficiency patients.
  • Participation is completely voluntary and confidential.

Vem kan vara berättigad?

To be part of this registry, you must have received a clear diagnosis from your doctor that confirms you have LAL Deficiency. Before you can officially join, you'll need to give your informed consent. This means a doctor or nurse will explain the study in detail, and you'll say yes (or your parent/guardian will say yes for you) to sharing your health information. This is a common and important step in all similar health registries to make sure you fully understand what's involved.

Another important point is that if you're currently taking part in a different clinical trial sponsored by a company called Alexion, you won't be able to join this registry at the same time. However, if you've already finished participating in an Alexion trial involving the medicine sebelipase alfa, you are welcome to join this registry. Also, being part of this registry won't stop you from joining another clinical trial in the future if you choose to.

Kan denna studie passa dig?

Svara på dessa snabba frågor för att se om du kan vara berättigad. Detta är endast en vägledning — forskarteamet fattar det slutgiltiga beslutet.

  1. Do I have a confirmed diagnosis of LAL Deficiency?
  2. Am I willing to have my routine health information collected?
  3. Am I currently participating in another Alexion-sponsored clinical trial? (If yes, I cannot join now.)
  4. Am I over 18, or do I have a parent/guardian who can consent for me?
Svara på varje fråga för att se ditt resultat.

Vad innebär deltagande?

This is an observational study, which means you won't be given any new medicines or treatments as part of the registry itself. Instead, your medical information will be collected from your regular doctor's visits and medical records. This includes details about your diagnosis, symptoms, how your condition progresses over time, and any treatments you are already receiving, such as sebelipase alfa.

There won't be any extra appointments or specific tests required just for this registry. The information will be gathered during your routine medical care. The goal is to track your health journey over a long period to see how LAL Deficiency affects people and how different approaches to care work. The total duration of your participation depends on how long the registry continues and how long you wish to share your data.

Potentiella risker och fördelar

Participating in this registry could offer potential benefits by helping researchers and doctors better understand LAL Deficiency, which could lead to improved care and treatments for all affected individuals in the future. There are very few direct risks to you as this is an observational study, meaning no new treatments or tests are involved beyond your usual care. The main consideration is ensuring the privacy of your health information, which the study aims to protect. You have the right to withdraw from the registry at any time, for any reason, and this decision will not affect your medical care.

Locations (104)

  • Klinisk Prövningsplats
    Verifierat postnummer
    Phoenix, USA· Rekrytering
  • Klinisk Prövningsplats
    Verifierat postnummer
    Stanford, USA· Rekrytering
  • Klinisk Prövningsplats
    Verifierat postnummer
    Miramar, United States· Rekrytering
  • Klinisk Prövningsplats
    Verifierat postnummer
    Orlando, USA· Rekrytering
  • Klinisk Prövningsplats
    Verifierat postnummer
    Atlanta, USA· Rekrytering
  • Klinisk Prövningsplats
    Verifierat postnummer
    Chicago, USA· Rekrytering
  • Klinisk Prövningsplats
    Verifierat postnummer
    Boston, USA· Rekrytering
  • Klinisk Prövningsplats
    Verifierat postnummer
    Detroit, USA· Rekrytering
  • Klinisk Prövningsplats
    Verifierat postnummer
    Minneapolis, USA· Rekrytering
  • Klinisk Prövningsplats
    Verifierat postnummer
    Jackson, USA· Rekrytering
  • Klinisk Prövningsplats
    Verifierat postnummer
    Hackensack, NJ, 7601, United States· Rekrytering
  • Klinisk Prövningsplats
    Verifierat postnummer
    New York, USA· Rekrytering

Vanliga frågor

What is LAL Deficiency?

It's a rare genetic condition where your body can't properly break down certain fats, causing them to build up in organs like the liver.

Kommer jag att få ny medicin i denna studie?

No, this is an observational study, meaning you won't be given new medicines or treatments as part of it. It collects information about your existing care.

Is my participation voluntary?

Yes, joining this registry is completely your choice (or your parents' choice if you're under 18) and you can leave at any time.

How will my health information be used?

Your de-identified health information will be used to better understand LAL Deficiency and improve care for others in the future.

Kommer jag att ha extra läkarbesök?

No, data will be collected from your regular medical visits, so you won't need extra appointments specifically for this registry.

Hur du får reda på mer

Alexion Pharmaceuticals, Inc. (Sponsor)

Prata alltid med din läkare eller specialist innan du bestämmer dig för att delta i en studie.

Intresserad av att delta?

Registrera ditt intresse

Dela dina uppgifter och forskarteamet för "Lysosomal Acid Lipase (LAL) Deficiency Registry…" kommer att kontakta dig om du kan vara berättigad. Prata alltid med din läkare innan du går med på att delta.

Diskussion

Gemenskapsdiskussion

Drivs av vårt forum på community.patient.info. Var vänlig och respektfull — detta är inte medicinsk rådgivning.